New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:00 EDTRADRite Aid benefiting from generic rebid and Cymbalta launch, says Cleveland
Cleveland Research said Rite Aid's gross profits are benefiting from a recent RFP for its generic business which will likely result in savings of 3% and the Cymbalta generic launch that is running above expectations, which should offset reimbursement pressures.
News For RAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
08:03 EDTRADCVS offering drug plan with higher co-pay at stores selling tobacco, WSJ says
CVS Health (CVS), which stopped selling tobacco products last month, is now offering a prescription-drug plan via its pharmacy benefits unit Caremark that charges patients copayments that are up to $15 higher on prescriptions filled where tobacco is sold, which includes at rival pharmacies operated by Walgreen (WAG) and Rite-Aid (RAD), reported The Wall Street Journal. Reference Link
October 13, 2014
10:08 EDTRADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:47 EDTRADRite Aid initiated with a Market Perform at Cowen
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use